Scientific Program

Conference Series LLC Ltd invites all the participants across the globe to attend 5th World Congress on Public Health, Nutrition & Epidemiology Melbourne, Australia.

Day 1 :

Public Health Congress 2018 International Conference Keynote Speaker Keshena Patterson  photo
Biography:

Keshena has a Bachelor’s of Science in Radiology Technology. She has worked as a Radiology Technologist for over 7 years. She has experience in a variety of positions including leadership. She currently works as a Clinical Education Specialist for Siemens Healthineers. She is also a respected independent author publishing a part memoir, part informational nonfiction book about her journey with PCOS(polycystic ovarian syndrome) called “I Kept My Smile, From A Girl To A Woman With: PCOS”. Her passion is self-love, patient care, raising awareness for PCOS, and to support and encourage women and young girls with PCOS to be fearless and take control. She is also a motivational speaker and has written publications in her career field and the PCOS community.

 

Abstract:

PCOS-Polycystic Ovarian Syndrome is a metabolic disorder that affects the hormones and endocrine system. This disorder affects so many young girls and women, it is said that 1 in 10 women of childbearing age have it and may not know it. Symptoms range from infertility, being overweight, cardiovascular issues, acne, unwanted hair, etc. Many specialized medical providers can treat PCOS patients but the beginning starts with Ultrasound imaging and lab work for diagnosis. Ultrasound provides images of the ovaries to understand if cysts are present.

 

Keynote Forum

Mohammod Jobayer Chisti

International Centre for Diarrhoeal Disease Research, Bangladesh

Keynote: Low cost innovative therapy in childhood pneumonia in developing countries

Time : 10:45-11:30

Public Health Congress 2018 International Conference Keynote Speaker Mohammod Jobayer Chisti photo
Biography:

Mohammod Jobayer Chisti has been working in International Centre for Diarrhoeal Disease Research, Bangladesh, since 1998.

 

Abstract:

Background & Aim: Even with WHO recommended appropriate antibiotics, standard Low Flow (LF) oxygen by nasal prongs and good supportive care case-fatality-rate from severe pneumonia in many hospitals is more than 10%. We need to understand the role of non-invasive ventilation such as Bubble CPAP (BCPAP) compared to LF oxygen therapy in managing children with severe pneumonia and hypoxemia in such children beyond the newborn period in developing countries.

Methodology: We included RCTs conducted in developing countries where BCPAP was compared with LF oxygen therapy for the treatment of World Health Organization (WHO) defined severe pneumonia and hypoxemia.

Results: Children who received BCPAP therapy had significant reduction in treatment failure (p<0.05) and deaths (p<0.05) compared to those who received LF therapy. No significant difference of SAEs was observed between the groups.

Conclusion: The results of our data revealed that BCPAP therapy had the significant better outcome compared to LF therapy. Thus, bubble CPAP therapy should be considered as a part of standard of care for treating children under five with severe pneumonia and hypoxemia in developing countries where still the part of the standard of care of severe pneumonia is WHO standard LF oxygen therapy.